News Archive
The results of a recent survey in Britain have led to announcements that Brits, in particular young female ones, are amongst the most promiscuous in the world.
A new project using artificial intelligence technology could spell a medical breakthrough for people suffering from, or at risk of, coronary artery disease, the single leading cause of death in Australia.
Abbott announced today that the U.S. Food and Drug Administration (FDA) will begin implementing Abbott's STARLIMS software-based laboratory information management system (LIMS) as part of the agency's initiative to enhance FDA testing laboratories.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.
The joy of a juicy hamburger could make a comeback thanks a new discovery by scientists from the University of Kentucky. In a new research report in the December 2010 print issue of The FASEB Journal, scientists found that a protein our body uses to break up blood clots speeds up the progress of prion diseases. This substance, called plasminogen, is a new drug target for prion diseases in both humans and animals.
› Verified 2 days ago